# clm_213E56FCF1C0

subject: AbbVie (/record/abbvie.md)  
predicate: cash_and_equivalents  
value: 5,175,000,000 United States dollar  
valid_from: 2025-03-31  
valid_to: 2025-06-30  
published: 2025-05-09  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_6EBD1BCE1675  
last_updated: 2026-11-08  
cite: AsOf. "AbbVie cash and equivalents: 5,175,000,000 United States dollar", as of 2025-03-31 (until 2025-06-30). Claim clm_213E56FCF1C0, https://asof.is/claim/clm_213E56FCF1C0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/0001551152-25-000029-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2025-05-09  

## Sources

- https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/0001551152-25-000029-index.htm (primary, SEC EDGAR 10-Q Q1 FY2025, published 2025-05-09)

## Supersedes

- [AbbVie](/record/abbvie.md) | cash_and_equivalents | 5,524,000,000 United States dollar | valid 2024-12-31 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_213E56FCF1C0](/claim/clm_213E56FCF1C0.md) | [clm_42142B046C44](/claim/clm_42142B046C44.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.